Antiepileptic Drug Monitoring

Overview

4.4 out of 5 (43 Reviews)

Credits

1.00

Post Assessment Questions

5

Start Date

1 Sep 2023

Last Review Date

1 May 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6669 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7920 hours of CE.

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$59 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$79 per 1 year per user
 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Antiepileptic drug-level monitoring has been a standard practice in managing seizures since the introduction of antiepileptic drugs or antiseizure medications. Conforming antiepileptic drug levels to predefined therapeutic margins proves elusive, as clinicians often inflate these values. This activity discusses the effectiveness, diversity, and relevance of monitoring antiepileptic drug levels across various clinical milieus.

The diagnosis of epilepsy primarily hinges on clinical evaluation, supported by adjunctive investigative modalities such as electroencephalogram and magnetic resonance imaging. Similarly, gauging antiepileptic drug efficacy relies on clinical appraisal, with antiepileptic drug levels as supplementary information in specific scenarios. A comprehensive understanding of evolving guidelines and research, coupled with adept critical analysis skills, are vital for deciphering antiepileptic drug levels within the context of individual patient presentations and treatment objectives. Furthermore, fostering a patient-centered approach mandates accounting for distinctive patient characteristics and preferences, coupled with effective communication regarding treatment regimens and the rationale behind antiepileptic drug monitoring. Equipping healthcare professionals with in-depth knowledge of antiepileptic drug monitoring protocols empowers them to actively engage in shared decision-making with patients, ultimately fostering superior treatment outcomes.


UAN: JA4008338-0000-23-5286-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Evaluate the misconception surrounding the practice of maintaining antiepileptic drugs within laboratory-defined therapeutic ranges.

  • Identify the efficacy, variability, and utility of monitoring antiepileptic drug levels in various settings.

  • Assess the clinical assessment of antiepileptic drug efficacy.

  • Implement effective collaboration and communication among interprofessional team members to improve outcomes for patients who might benefit from antiepileptic drug monitoring.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.00 ACPE credit(s). (UAN: JA4008338-0000-23-5286-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Sarah H. on 4/18/2022

we should able to communicate with person on phone when we have difficulty rather than go forth & back on email

Manoj v. on 5/8/2022

Daniela E. on 4/17/2023

Nivetha V. on 11/13/2023

bogdana t. on 12/10/2023

Likta N. on 1/11/2024

Vu H. on 10/27/2023

Dr Jagveer S. on 9/30/2023

bogdana t. on 3/8/2024

Howard R. on 9/18/2023

VLADIMIR E. on 8/28/2023

Adithya nikhileshwar B. on 7/1/2023

Akshaya K. on 4/24/2023

Huntington on 4/13/2023

Dr Jagveer S. on 12/10/2022

Catherine K. on 11/3/2022

MANJARI G. on 7/14/2022

ROBERT S. on 5/17/2024

Rohit A. on 7/4/2022

Lovely Faith R. on 7/24/2024

Emmy K. on 5/10/2022

Jacinta U. on 5/10/2022

Dr.Mallikarjun K. on 5/10/2022

Surabhi C. on 3/24/2022

Micheal M. on 2/21/2022

Michael N. on 2/10/2022

Sherryl E. on 2/3/2022

Lynn S. on 1/25/2022

Cherie T. on 12/31/2021

Micheal M. on 11/19/2021

Claire H. on 10/17/2021

John L. on 10/1/2021

Thomas M. on 1/15/2024

Matthew S. on 1/29/2024

Malani K. on 2/6/2024

Yashma P. on 3/26/2024

Jennifer G. on 4/9/2024

Antonio V. on 4/11/2024

Tanya T. on 4/23/2024

Kaashif A. on 4/27/2024

mariam g. on 5/4/2024

Dr. Neha K. on 5/14/2024

Daniel S. on 6/23/2024

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6669 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7920 hours of CE.

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$59 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$79 per 1 year per user